Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

Example Input: Paragraph: Tuesday is the final day of Sexually Transmitted Disease Awareness Month, and the state CDC says it’s recommending prevention, screening and treatment. The agency says Maine has seen “dramatic increases” in gonorrhea and syphilis in the last five years. Gonorrhea cases increased nearly 200 percent, to 686, from 2014 to 2018. Syphilis cases have risen by almost 600 percent, to 104, in that same timeframe. Acting Maine CDC Director Nancy Beardsley says the health consequences of sexually transmitted infections are serious enough that residents “know the facts about STDs and get tested if they believe they are at risk.” Claim: Maine stresses test as sexually transmitted infections surge.
Example Output: The Maine Center for Disease Control and Prevention is calling on residents to get tested for sexually transmitted infections amid a spike in cases of gonorrhea and syphilis in the state.

Example Input: Paragraph: A nurse prepares a bottle of donated milk for a baby at Son Dureta's Hospital in Palma de Mallorca, Spain March 10, 2006. REUTERS/Dani Cardona The chemical bisphenol A, or BPA, is commonly used in plastic food and beverage containers and in the coating of food cans. Until now, environmental and consumer activists who have questioned the safety of BPA have relied on animal studies. But the study by British researchers in the Journal of the American Medical Association found that among 1,455 U.S. adults, those with the highest levels of BPA were more likely to have heart disease, diabetes and liver-enzyme abnormalities than those with the lowest levels. U.S. Food and Drug Administration officials said they would review the new findings, which were not yet published when the agency issued a draft conclusion in August that BPA is safe at current exposure levels. “We have confidence in the data that we’ve looked at and the data that we’re relying on to say that the margin of safety is adequate,” FDA official Laura Tarantino said at a meeting of experts advising the agency on whether it made the right call. “There are things you can do if you choose to reduce your level of bisphenol A,” Tarantino said. “But we have not recommended that anyone change their habits or change their use of any of these products because right now we don’t have the evidence in front of us to suggest that people need to.”   Panel chairman Martin Philbert declined to say what the committee’s next move would be. BPA is used to make polycarbonate plastic, a clear shatter-resistant material in products ranging from baby bottles to medical devices. BPA can mimic the hormone estrogen in the body. People can consume BPA when it leaches out of the plastic into baby formula, water or food inside a container. Some retailers and manufacturers are moving away from products with BPA. Canadian officials have concluded BPA was harmful. Steven Hentges of the American Chemistry Council, an industry group, said the study’s design did not allow for anyone to conclude BPA causes heart disease and diabetes. “On the other hand, though, bisphenol A has been very intensively studied in a very large number of laboratory animal studies. And the weight of evidence from those studies ... continues to support the safe use of products containing bisphenol A,” he said in a telephone interview. The British researchers, who acknowledged their findings are not proof that the chemical is causing the harm, analyzed urine samples from a U.S. government health survey of adults ages 18-74 representative of the U.S. population. The 25 percent of people with the highest levels of bisphenol A in their bodies were more than twice as likely to have heart disease, including heart attacks or type 2 diabetes, compared to the 25 percent with the lowest levels. At the FDA panel meeting, several scientists and activists said the FDA ignored animal studies finding health concerns and some called for the chemical to be banned in food containers. Democratic U.S. Rep. John Dingell of Michigan, who heads the House Committee on Energy and Commerce, said the FDA has “focused myopically on industry-funded research.”   Iowa Republican Sen. Chuck Grassley, ranking member of the Committee on Finance, released a letter he wrote to FDA Commissioner Dr. Andrew von Eschenbach asking why the agency has not appointed a safety panel to review BPA. Tarantino said nothing was ignored but industry-funded studies finding no harm were important in the conclusions. The panel is expected to present its advice to the FDA next month. Tarantino, head of the FDA’s office of food additive safety, said there is talk of government scientists doing their own BPA safety studies, but that could take years to conduct. Claim: Common plastics chemical linked to heart problems.
Example Output: A major study links a chemical widely used in plastic products, including baby bottles, to health problems in humans like heart disease and diabetes, but U.S. regulators said on Tuesday they still believe it is safe.

Example Input: Paragraph: True, the news hit hard last month that the so-called “Boston patients” - two men who received bone marrow transplants that appeared to rid them completely of the AIDS-causing virus - had relapsed and gone back onto antiretroviral treatment. But experts say the disappointment could lay the basis for important leaps forward in the search for a cure. “It’s a setback for the patients, of course, but an advance for the field because the field has now gained a lot more knowledge,” said Steven Deeks, a professor and HIV expert at the University of California, San Francisco. He and other experts say the primary practical message is that current tests designed to detect even very low levels of HIV present in the body are simply not sensitive enough. As well as having the human immunodeficiency virus (HIV), the Boston patients both also had a type of blood cancer called lymphoma, for which they were treated using bone marrow transplants - one man in 2008 and the other in 2010. They continued taking the antiretroviral AIDS drugs, but eight months after each patient’s transplant, doctors found they could not detect any sign of HIV in their blood. In the early part of 2013, both patients decided to stop taking their AIDS drugs and both appeared to remain HIV-free - prompting their doctors, Timothy Henrich and Daniel Kuritzkes from Boston’s Brigham and Women’s Hospital, to announce at a conference in July that they may have been cured. Yet in December came news that one of the men had begun to show signs of an HIV rebound by August, while the second patient had a relapse in November. Henrich said the virus’ comeback underlined how ingenious HIV can be in finding hiding places in the body to evade attack efforts by the immune system and by drug treatment. “Through this research we have discovered the HIV reservoir is deeper and more persistent than previously known and that our current standards of probing for HIV may not be sufficient,” he said, adding that both patients were “currently in good health” and back on antiretroviral therapy. Barely a decade ago, few HIV scientists would have dared put the words HIV and cure in the same sentence. Yet some intriguing and inspiring cases in recent years mean many now believe it is just a question of time before a cure is found. First was the now famous case of Timothy Ray Brown, the so-called “Berlin patient,” whose HIV was eradicated by a complex treatment for leukemia in 2007 involving the destruction of his immune system and a stem cell transplant from a donor with a rare genetic mutation that resists HIV infection. Such an elaborate, expensive and life-threatening procedure could never be used as a broad-spectrum approach for the world’s 34 million HIV patients. But the results in Brown focused scientific attention on a genetic mutation known as ‘CCR5 delta 32’ as a target for possible gene therapy treatment. Then last March, French scientists who followed 14 HIV-positive people known as the “Visconti patients”, who were treated very swiftly with HIV drugs but then stopped treatment, said that even after seven years off therapy, they were still showing no signs of the virus rebounding. That announcement came only weeks after news of the “functional cure” of an HIV-positive baby in Mississippi who received antiretroviral treatment for 18 months from the day she was born. By the time she was two this appeared to have stopped the virus replicating and spreading. A “functional cure” is when HIV is reduced to such low levels that it is kept at bay even without treatment, though the virus can still be detected in the body. Sharon Lewin, an HIV expert at Monash University in Australia, said all these developments, as well as the setback suffered by the Boston patients, inspired scientists to investigate many different approaches in the search for a cure. “We’ve learnt many things here - and one of the most important is that a tiny, tiny amount of virus can get the whole thing going again,” she told Reuters. “It’s a clear message that we need better ways to pick up the virus.”  Scientists are now more convinced than ever that a two-pronged approach which aims to firmly suppress the virus while bolstering the immune system provides the best way forward. “We need to attack in two ways - reduce the virus to very low levels and also to boost the immune response. We can’t do one without the other,” said Lewin. “So we still have to think of other creative ways to control HIV. And it’s still early days... before we can say which approach is likely to be the winner.” Claim: Relapse of 'cured' HIV patients spurs AIDS science on.
Example Output:
Scientists seeking a cure for AIDS say they have been inspired, not crushed, by a major setback in which two HIV positive patients believed to have been cured found the virus re-invading their bodies once more.